医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Aster DM Healthcare Unveil AED 126 Million Quaternary Care Hospital in Bangalore – India

2016年09月01日 PM08:54
このエントリーをはてなブックマークに追加


 

DUBAI, United Arab Emirates

Dubai-based conglomerate, Aster DM Healthcare, have formally launched its newly upgraded Quaternary Care Super-specialty healthcare facility Aster CMI Hospital at Hebbal, Bengaluru.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20160901005682/en/

Newly 509 bed Aster CMI Hospital, Bangalore - India (Photo: ME NewsWire)

Newly 509 bed Aster CMI Hospital, Bangalore – India (Photo: ME NewsWire)

• The Aster CMI Hospital is the epitome of advanced modern healthcare with dedicated Centers of Excellence in Cardiac-Sciences, Neuro-Sciences, Gastro-Sciences, General & Lapro Surgery, Integrated Liver Care, Organ Transplant, Urology & Nephrology, Orthopaedics, Women, Child and Adolescent Health.

• Aster CMI Hospital features cutting-edge technology such as 3 Tesla MRI, 128 Slice CT Scanner and a Hybrid Cath lab.

• The Super-speciality Hospital includes 12 Modular Operation Theatres, a dedicated transplant ICU and Bone Marrow Transplant Unit, NABL accredited Clinical Lab and a Blood Bank

▪ The Hospital was inaugurated by legendary cricketer Shri Sachin Tendulkar in the presence of Dr. Azad Moopen, Chairman & Managing Director of Aster DM Healthcare and several dignitaries.

Dr. Azad Moopen addressing the gathered said, “The Aster CMI Hospital is testament to our mission in bringing world-class medical care to India. With an investment outlay of around Rs.230 crores (AED 230 million), Aster CMI Hospital aims to provide medical care in accordance with global best practices in healthcare. Designed to make the patients ‘feel better to heal better’, the hospital imbibes our core philosophy ‘We’ll Treat You Well’, carrying forward our legacy of excellence with professionalism and dedication.”

Sachin Tendulkar congratulated Dr. Moopen and the Aster DM Healthcare family on the opening of another super-speciality healthcare facility in India. He said, “My relationship with healthcare runs very long thanks to the multiple injuries throughout my career. In fact, I would not have been able to serve Indian cricket and chase my dreams but for the support and care of many medical professionals and physiotherapists!”

Aster DM Healthcare took over the operations of Cauvery Medical Centre in May 2014 and revamped the facility to a quaternary care multi-Specialty facility with now 509 beds & many centers of excellence. It can now cater to the requirements of Regional, National & International patients seeking quality & affordable healthcare services at Hebbal in Bangalore – the IT capital of India, well connected to the International Airport. Aster CMI also has a well-designed outpatient department offering preventive, diagnostic, curative and rehabilitative services. The comprehensive services include immunisation, health screening, laboratory and radiology services and minor surgical procedures.

*Source: ME NewsWire

View source version on businesswire.com: http://www.businesswire.com/news/home/20160901005682/en/

CONTACT

Aster DM Healthcare
Jaleel PA, +97155-7009-010
jaleel@dmhealthcare.com
Aakash
Roy, +97155-7009-498
aakash.roy@dmhealthcare.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • 武田薬品がALK陽性非小細胞肺がんでのALUNBRIGTM(ブリガチニブ)のピボタル第2相ALTA試験の最新データを発表
  • Shinkowa Pharmaceutical Co., Ltd., Distributor of the World’s First Supplements Containing β-Nicotinamide Mononucleotide (NMN), Has Begun World-Wide Distribution of the Special Products “NMN PURE 3000″ and “NMN PURE 1500″
  • Interim Analysis of Ignyta’s Entrectinib Suggests Potential Best-in-Class Profile as a First-Line Targeted Therapy in Patients With ROS1-Positive Non-Small Cell Lung Cancer
  • Spectrum Pharmaceuticals Highlights Poziotinib Data in Non-Small-Cell Lung Cancer (NSCLC) Presented at the 18th IASLC World Conference on Lung Cancer in Japan
  • 武田呈报ALUNBRIGTM (brigatinib)治疗ALK阳性非小细胞肺癌枢纽性2期ALTA试验的更新结果